Literature DB >> 20600740

Chronic electrical stimulation does not prevent spiral ganglion cell degeneration in deafened guinea pigs.

Martijn J H Agterberg1, Huib Versnel, John C M J de Groot, Marloes van den Broek, Sjaak F L Klis.   

Abstract

Several studies have demonstrated that treatment with intracochlear chronic electrical stimulation (CES) protects spiral ganglion cells (SGCs) from degeneration in deafened animals. Other studies could not confirm this effect of CES. The present study examined whether CES in a mode as presented in cochlear implant users (amplitude modulated, high pulse rate) affects survival, morphology and functionality of SGCs in deafened guinea pigs. Eleven guinea pigs were implanted in the right cochlea with an electrode array to monitor the electrically evoked auditory brainstem responses (eABRs). The guinea pigs were deafened four weeks later. Two days after deafening, monopolar CES was started in five animals through three electrodes in the basal cochlear turn. CES lasted 4 hours per day, five days per week, for six weeks. SGC packing densities, perikaryal area, cell circularity, amplitudes of suprathreshold eABRs and eABR thresholds were not affected by CES. SGCs of all implanted cochleae were larger and more circular than SGCs in unimplanted cochleae, but this did not depend on CES treatment. Interestingly, an increase in eABR latencies observed after deafening, occurred faster in CES-treated than in untreated animals. In conclusion, amplitude-modulated chronic electrical stimulation with a high pulse rate does not affect survival, morphology and functionality of spiral ganglion cells with the exception of eABR latencies.

Entities:  

Mesh:

Year:  2010        PMID: 20600740     DOI: 10.1016/j.heares.2010.06.015

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  9 in total

1.  Combining cell-based therapies and neural prostheses to promote neural survival.

Authors:  Andrew K Wise; James B Fallon; Alison J Neil; Lisa N Pettingill; Marilyn S Geaney; Stephen J Skinner; Robert K Shepherd
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

2.  Miniature pigs: a large animal model of cochlear implantation.

Authors:  Haijin Yi; Weiwei Guo; Wei Chen; Lei Chen; Jingying Ye; Shiming Yang
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

3.  Factors associated with hearing loss in a normal-hearing guinea pig model of Hybrid cochlear implants.

Authors:  Chiemi Tanaka; Anh Nguyen-Huynh; Katherine Loera; Gemaine Stark; Lina Reiss
Journal:  Hear Res       Date:  2014-08-14       Impact factor: 3.208

4.  Spiral ganglion neuron survival and function in the deafened cochlea following chronic neurotrophic treatment.

Authors:  Thomas G Landry; Andrew K Wise; James B Fallon; Robert K Shepherd
Journal:  Hear Res       Date:  2011-07-06       Impact factor: 3.208

5.  Temporary Neurotrophin Treatment Prevents Deafness-Induced Auditory Nerve Degeneration and Preserves Function.

Authors:  Dyan Ramekers; Huib Versnel; Stefan B Strahl; Sjaak F L Klis; Wilko Grolman
Journal:  J Neurosci       Date:  2015-09-09       Impact factor: 6.167

6.  Influence of cAMP and protein kinase A on neurite length from spiral ganglion neurons.

Authors:  Ningyong Xu; Jonathan Engbers; Sobia Khaja; Linjing Xu; J Jason Clark; Marlan R Hansen
Journal:  Hear Res       Date:  2011-12-03       Impact factor: 3.208

Review 7.  Nerve maintenance and regeneration in the damaged cochlea.

Authors:  Seiji B Shibata; Cameron L Budenz; Sara A Bowling; Bryan E Pfingst; Yehoash Raphael
Journal:  Hear Res       Date:  2011-05-10       Impact factor: 3.208

8.  Effect of monopolar and bipolar electric stimulation on survival and size of human spiral ganglion cells as studied by postmortem histopathology.

Authors:  Mohammad Seyyedi; Donald K Eddington; Joseph B Nadol
Journal:  Hear Res       Date:  2013-05-06       Impact factor: 3.208

9.  A physiological and behavioral system for hearing restoration with cochlear implants.

Authors:  Julia King; Ina Shehu; J Thomas Roland; Mario A Svirsky; Robert C Froemke
Journal:  J Neurophysiol       Date:  2016-06-08       Impact factor: 2.714

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.